HomeCAMP • NASDAQ
CAMP4 Therapeutics Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 652.00K | — |
Operating expense | 4.69M | 66.61% |
Net income | -13.28M | -2.22% |
Net profit margin | -2.04K | — |
Earnings per share | — | — |
EBITDA | -13.62M | -4.41% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 64.04M | 66.86% |
Total assets | 78.31M | 42.52% |
Total liabilities | 15.16M | -8.26% |
Total equity | 63.14M | — |
Shares outstanding | 20.15M | — |
Price to book | 0.97 | — |
Return on assets | -70.40% | — |
Return on capital | -82.86% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -13.28M | -2.22% |
Cash from operations | -11.29M | 4.20% |
Cash from investing | -263.00K | -8.23% |
Cash from financing | 73.06M | 116,071.43% |
Net change in cash | 61.51M | 608.82% |
Free cash flow | -9.31M | — |
Previous close
$3.03
Day range
$2.44 - $2.97
Year range
$0.39 - $12.30
Market cap
52.42M USD
Avg Volume
27.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Website
Employees
55
